NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Income Statement
TSX-V:NGMD - TSX Venture Exchange - CA67054F1009 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 762.80K | 331.40K | 152.40K | 137.70K | |||
| Cost Of Goods | 404.20K | 166.60K | 53.20K | 45.40K | |||
| Gross Profit | 358.60K | 164.80K | 99.20K | 92.20K | |||
| Operating Expenses | 6.84M | 8.21M | 4.89M | 7.76M | |||
| Selling, General, and Administrative Expenses | 6.20M | 7.52M | 4.24M | 5.26M | |||
| Operating Income | -6.49M | -8.05M | -4.79M | -7.67M | |||
| Interest Income/Expense | -1.83M | -1.35M | -1.11M | -978.90K | |||
| Other Income/Expense | -460.30K | 60.50K | 181.00K | 669.60K | |||
| Non Recurring Items | N/A | 9.00K | 150.90K | 876.50K | |||
| Income Before Taxes | -8.27M | -9.33M | -5.57M | -7.10M | |||
| Income Tax | 36.20K | 33.80K | 3.20K | 3.00K | |||
| Net Income | -8.31M | -9.36M | -5.58M | -7.11M | |||
| EBITDA | -5.85M | -7.36M | -4.14M | -6.88M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.04 | -0.06 | -0.06 | -0.10 | |||
| Statistics | |||||||
| Gross Profit Margin | 47.01% | 49.73% | 65.09% | 66.96% | |||
| Profit Margin | -1089.43% | -2825.05% | -3660.04% | -5161.29% | |||
| Operating Profit Margin | -850.30% | -2428.52% | -3145.67% | -5571.02% | |||
All data in CAD